PAR-3 Agonist (Mouse) – GPCR Modulators

Protease activated receptors (PARs) are a distinctive four-member family of seven transmembrane G protein-coupled receptors (GPCRs) widely expressed in inflammatory cells. PARs are cleaved by certain serine proteases to expose a tethered ligand domain, this ligand domain then binds to and activates the receptors to initiate multiple signalling cascades. These PAR-activating proteases therefore represent PAR agonists. This PAR-2 agonist peptide mimics the sequence of the ‘tethered ligand’ and is therefore capable of activating the receptor independently of N-terminal proteolysis. PAR-3 is required for intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells and PAR-3 cooperates with PAR-1 to mediate the effect of thrombin on cytokine production and vascular cell adhesion molecule (VCAM-) 1 expression. PAR activation has been linked to inflammation, therefore compounds that mimic or interfere with the PAR-activating processes are attractive therapeutic candidates.

 

Technical specification

 KD20 peptide Sequence : H-SFNGGP-NH2
 KD20 peptide MW : 576.3 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1000561-0.5 mg 0.5 mg 141 € 113 $
CRB1000561-1 mg 1 mg 193 € 154 $
CRB1000561-5 mg 5 mg 385 € 308 $
CRB1000561-
CRB1000561-

For Bulk Orders